Vertex Pharmaceuticals Gross Margin 2010-2024 | VRTX

Current and historical gross margin for Vertex Pharmaceuticals (VRTX) over the last 10 years. The current gross profit margin for Vertex Pharmaceuticals as of September 30, 2024 is %.
Vertex Pharmaceuticals Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-09-30 $10.63B $9.15B 86.11%
2024-06-30 $10.34B $8.94B 86.44%
2024-03-31 $10.19B $8.85B 86.86%
2023-12-31 $9.87B $8.61B 87.21%
2023-09-30 $9.66B $8.48B 87.80%
2023-06-30 $9.51B $8.36B 87.92%
2023-03-31 $9.21B $8.11B 88.03%
2022-12-31 $8.93B $7.85B 87.90%
2022-09-30 $8.70B $7.66B 87.99%
2022-06-30 $8.35B $7.36B 88.12%
2022-03-31 $7.95B $6.99B 87.95%
2021-12-31 $7.57B $6.67B 88.06%
2021-09-30 $7.13B $6.27B 87.95%
2021-06-30 $6.68B $5.87B 87.89%
2021-03-31 $6.41B $5.65B 88.07%
2020-12-31 $6.21B $5.47B 88.15%
2020-09-30 $5.99B $5.27B 88.03%
2020-06-30 $5.40B $4.74B 87.73%
2020-03-31 $4.82B $4.21B 87.26%
2019-12-31 $4.16B $3.62B 86.86%
2019-09-30 $3.62B $3.14B 86.63%
2019-06-30 $3.45B $2.99B 86.57%
2019-03-31 $3.27B $2.83B 86.74%
2018-12-31 $3.05B $2.64B 86.55%
2018-09-30 $2.83B $2.46B 86.86%
2018-06-30 $2.62B $2.29B 87.30%
2018-03-31 $2.42B $2.12B 87.58%
2017-12-31 $2.49B $2.21B 88.95%
2017-09-30 $2.30B $2.04B 89.02%
2017-06-30 $2.13B $1.90B 89.07%
2017-03-31 $2.02B $1.81B 89.70%
2016-12-31 $1.70B $1.49B 87.55%
2016-09-30 $1.66B $1.45B 87.12%
2016-06-30 $1.56B $1.37B 87.68%
2016-03-31 $1.29B $1.13B 87.38%
2015-12-31 $1.03B $0.91B 87.90%
2015-09-30 $0.76B $0.68B 90.00%
2015-06-30 $0.63B $0.57B 90.78%
2015-03-31 $0.60B $0.54B 90.35%
2014-12-31 $0.58B $0.52B 89.66%
2014-09-30 $0.79B $0.72B 91.35%
2014-06-30 $0.83B $0.75B 90.11%
2014-03-31 $1.00B $0.90B 89.72%
2013-12-31 $1.21B $1.08B 89.27%
2013-09-30 $1.20B $1.00B 83.60%
2013-06-30 $1.31B $1.10B 84.19%
2013-03-31 $1.42B $1.13B 80.01%
2012-12-31 $1.53B $1.25B 81.66%
2012-09-30 $1.76B $1.53B 87.36%
2012-06-30 $2.08B $1.86B 89.37%
2012-03-31 $1.78B $1.66B 93.46%
2011-12-31 $1.41B $1.33B 94.33%
2011-09-30 $0.91B $0.86B 94.09%
2011-06-30 $0.28B $0.26B 93.17%
2011-03-31 $0.20B $0.18B 93.37%
2010-12-31 $0.14B $0.13B 90.97%
2010-09-30 $0.11B $0.10B 88.39%
2010-06-30 $0.11B $0.10B 87.61%
2010-03-31 $0.10B $0.09B 86.00%
2009-12-31 $0.10B $0.09B 85.29%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $119.524B $9.869B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $147.316B 14.26
Gilead Sciences (GILD) United States $115.130B 20.85
Bristol Myers Squibb (BMY) United States $114.146B 48.10
CSL (CSLLY) Australia $85.472B 0.00
Regeneron Pharmaceuticals (REGN) United States $81.425B 18.53
GSK (GSK) United Kingdom $70.819B 8.19
Argenex SE (ARGX) Netherlands $36.426B 0.00
Alnylam Pharmaceuticals (ALNY) United States $31.634B 0.00
BioNTech SE (BNTX) Germany $28.691B 0.00
Illumina (ILMN) United States $23.224B 84.64
Biogen (BIIB) United States $22.635B 9.72
BeiGene (BGNE) Cayman Islands $17.564B 0.00
Moderna (MRNA) United States $16.478B 0.00
Genmab (GMAB) Denmark $13.666B 20.05
Incyte (INCY) United States $13.645B 0.00
Insmed (INSM) United States $12.890B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.628B 29.32
Bio-Techne Corp (TECH) United States $12.184B 47.04
Sarepta Therapeutics (SRPT) United States $11.889B 107.30
Exact Sciences (EXAS) United States $11.569B 0.00
Vaxcyte (PCVX) United States $10.952B 0.00
QIAGEN (QGEN) Netherlands $10.488B 21.58
Exelixis (EXEL) United States $10.047B 22.84
Bio-Rad Laboratories (BIO.B) United States $9.437B 32.07
Intra-Cellular Therapies (ITCI) United States $8.842B 0.00
Repligen (RGEN) United States $8.740B 113.86
Roivant Sciences (ROIV) United Kingdom $8.648B 0.00
Ascendis Pharma (ASND) Denmark $7.922B 0.00
Revolution Medicines (RVMD) United States $7.558B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.472B 7.31
Legend Biotech (LEGN) United States $6.482B 0.00
Nuvalent (NUVL) United States $6.169B 0.00
Halozyme Therapeutics (HALO) United States $6.085B 13.74
Cytokinetics (CYTK) United States $5.928B 0.00
Blueprint Medicines (BPMC) United States $5.881B 0.00
Viking Therapeutics (VKTX) United States $5.334B 0.00
Telix Pharmaceuticals (TLX) Australia $5.222B 0.00
Krystal Biotech (KRYS) United States $4.987B 82.57
Alkermes (ALKS) Ireland $4.935B 16.58
TG Therapeutics (TGTX) United States $4.777B 0.00
Axsome Therapeutics (AXSM) United States $4.573B 0.00
Arcellx (ACLX) United States $4.511B 0.00
ADMA Biologics Inc (ADMA) United States $4.413B 46.67
Ultragenyx Pharmaceutical (RARE) United States $4.330B 0.00
Guardant Health (GH) United States $4.317B 0.00
Apellis Pharmaceuticals (APLS) United States $4.073B 0.00
Biohaven (BHVN) United States $4.061B 0.00
Immunovant (IMVT) United States $4.050B 0.00
Avidity Biosciences (RNA) United States $4.028B 0.00
Scholar Rock Holding (SRRK) United States $3.899B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.875B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.436B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.422B 0.00
Denali Therapeutics (DNLI) United States $3.378B 0.00
NovoCure (NVCR) Jersey $3.253B 0.00
Janux Therapeutics (JANX) United States $3.228B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.189B 0.00
Amicus Therapeutics (FOLD) United States $3.033B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.008B 0.00
Zai Lab (ZLAB) China $2.903B 0.00
SpringWorks Therapeutics (SWTX) United States $2.878B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.872B 22.13
Vera Therapeutics (VERA) United States $2.857B 0.00
Merus (MRUS) Netherlands $2.838B 0.00
Vericel (VCEL) United States $2.814B 950.17
Twist Bioscience (TWST) United States $2.813B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.766B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.755B 0.00
Kymera Therapeutics (KYMR) United States $2.731B 0.00
Edgewise Therapeutics (EWTX) United States $2.665B 0.00
Iovance Biotherapeutics (IOVA) United States $2.426B 0.00
Protagonist Therapeutics (PTGX) United States $2.407B 15.18
Geron (GERN) United States $2.370B 0.00
Beam Therapeutics (BEAM) United States $2.324B 0.00
NeoGenomics (NEO) United States $2.298B 0.00
IDEAYA Biosciences (IDYA) United States $2.228B 0.00
Bavarian Nordic (BVNRY) Denmark $2.192B 13.44
Agios Pharmaceuticals (AGIO) United States $2.177B 0.00
Ligand Pharmaceuticals (LGND) United States $2.145B 53.54
ImmunityBio (IBRX) United States $2.118B 0.00
WAVE Life Sciences (WVE) Singapore $2.112B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.030B 0.00
Akero Therapeutics (AKRO) United States $2.026B 0.00
Apogee Therapeutics (APGE) United States $1.996B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.953B 0.00
CG Oncology (CGON) United States $1.952B 0.00
Belite Bio (BLTE) United States $1.940B 0.00
Disc Medicine (IRON) United States $1.913B 0.00
Certara (CERT) United States $1.885B 53.23
Fortrea Holdings (FTRE) United States $1.818B 57.91
Harmony Biosciences Holdings (HRMY) United States $1.817B 15.10
Structure Therapeutics (GPCR) United States $1.816B 0.00
MannKind (MNKD) United States $1.806B 46.79
Galapagos (GLPG) Belgium $1.778B 0.00
Celldex Therapeutics (CLDX) United States $1.755B 0.00
Neumora Therapeutics (NMRA) United States $1.709B 0.00
Dynavax Technologies (DVAX) United States $1.708B 99.92
Arcus Biosciences (RCUS) United States $1.570B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.516B 0.00
Nurix Therapeutics (NRIX) United States $1.456B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.454B 0.00
Novavax (NVAX) United States $1.445B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.434B 0.00
Viridian Therapeutics (VRDN) United States $1.425B 0.00
Travere Therapeutics (TVTX) United States $1.398B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.389B 0.00
MiMedx (MDXG) United States $1.387B 36.31
Intellia Therapeutics (NTLA) United States $1.381B 0.00
Arvinas (ARVN) United States $1.356B 0.00
Praxis Precision Medicines (PRAX) United States $1.323B 0.00
Myriad Genetics (MYGN) United States $1.320B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.292B 0.00
Spyre Therapeutics (SYRE) United States $1.230B 0.00
ANI Pharmaceuticals (ANIP) United States $1.189B 16.21
Mesoblast (MESO) Australia $1.185B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.150B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.146B 0.00
Upstream Bio (UPB) United States $1.094B 0.00
Vir Biotechnology (VIR) United States $1.023B 0.00
Septerna (SEPN) United States $1.002B 0.00
Bicara Therapeutics (BCAX) United States $0.982B 0.00
Liquidia Technologies (LQDA) United States $0.932B 0.00
Poseida Therapeutics (PSTX) United States $0.929B 0.00
Cogent Biosciences (COGT) United States $0.921B 0.00
Gyre Therapeutics (GYRE) United States $0.915B 0.00
Pacira BioSciences (PCRX) United States $0.914B 8.61
Adaptive Biotechnologies (ADPT) United States $0.909B 0.00
Nuvation Bio (NUVB) United States $0.885B 0.00
Immatics (IMTX) Germany $0.884B 0.00
ArriVent BioPharma (AVBP) United States $0.872B 0.00
AbCellera Biologics (ABCL) Canada $0.871B 0.00
Zymeworks (ZYME) United States $0.869B 0.00
LENZ Therapeutics (LENZ) United States $0.846B 0.00
Pliant Therapeutics (PLRX) United States $0.843B 0.00
Replimune (REPL) United States $0.836B 0.00
Cytek Biosciences (CTKB) United States $0.833B 0.00
89BIO (ETNB) United States $0.833B 0.00
Immunome (IMNM) United States $0.816B 0.00
Castle Biosciences (CSTL) United States $0.816B 145.60
Avid Bioservices (CDMO) United States $0.787B 0.00
Tyra Biosciences (TYRA) United States $0.768B 0.00
Kura Oncology (KURA) United States $0.754B 0.00
Keros Therapeutics (KROS) United States $0.747B 0.00
Erasca (ERAS) United States $0.744B 0.00
Prothena (PRTA) Ireland $0.743B 0.00
UniQure (QURE) Netherlands $0.734B 0.00
CureVac (CVAC) Germany $0.716B 5.82
Autolus Therapeutics (AUTL) United Kingdom $0.716B 0.00
Cullinan Therapeutics (CGEM) United States $0.710B 0.00
Anavex Life Sciences (AVXL) United States $0.704B 0.00
GRAIL (GRAL) United States $0.698B 0.00
Dianthus Therapeutics (DNTH) United States $0.696B 0.00
Rapport Therapeutics (RAPP) United States $0.695B 0.00
CARGO Therapeutics (CRGX) United States $0.688B 0.00
MBX Biosciences (MBX) United States $0.685B 0.00
Tectonic Therapeutic (TECX) United States $0.684B 0.00
Entrada Therapeutics (TRDA) United States $0.678B 11.40
Arbutus Biopharma (ABUS) United States $0.675B 0.00
Oculis Holding AG (OCS) Switzerland $0.672B 0.00
Stoke Therapeutics (STOK) United States $0.653B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Pharming Group (PHAR) Netherlands $0.632B 0.00
Mineralys Therapeutics (MLYS) United States $0.606B 0.00
Oric Pharmaceuticals (ORIC) United States $0.595B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.594B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.579B 0.00
Terns Pharmaceuticals (TERN) United States $0.560B 0.00
Astria Therapeutics (ATXS) United States $0.554B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.546B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.542B 0.00
CorMedix Inc (CRMD) United States $0.532B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.519B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.515B 0.00
Humacyte (HUMA) United States $0.514B 0.00
Cartesian Therapeutics (RNAC) United States $0.511B 0.00
Third Harmonic Bio (THRD) United States $0.507B 0.00
PureTech Health (PRTC) United States $0.501B 0.00
IGM Biosciences (IGMS) United States $0.489B 0.00
ChromaDex (CDXC) United States $0.487B 638.00
Abivax SA (ABVX) France $0.485B 0.00
Annexon (ANNX) United States $0.481B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.479B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.475B 0.00
Emergent Biosolutions (EBS) United States $0.471B 0.00
MeiraGTx Holdings (MGTX) United States $0.470B 0.00
Celcuity (CELC) United States $0.468B 0.00
MaxCyte (MXCT) United States $0.459B 0.00
Codexis (CDXS) United States $0.458B 0.00
AnaptysBio (ANAB) United States $0.457B 0.00
Sana Biotechnology (SANA) United States $0.455B 0.00
Kodiak Sciences (KOD) United States $0.440B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.438B 0.00
REGENXBIO (RGNX) United States $0.432B 0.00
Allogene Therapeutics (ALLO) United States $0.424B 0.00
Absci (ABSI) United States $0.423B 0.00
Aura Biosciences (AURA) United States $0.422B 0.00
Alpha Teknova (TKNO) United States $0.420B 0.00
Alumis (ALMS) United States $0.412B 0.00
GH Research (GHRS) Ireland $0.402B 0.00
Sangamo Therapeutics (SGMO) United States $0.399B 0.00
Prime Medicine (PRME) United States $0.395B 0.00
Northwest Biotherapeutics (NWBO) United States $0.388B 0.00
Zenas BioPharma (ZBIO) United States $0.387B 0.00
Olema Pharmaceuticals (OLMA) United States $0.385B 0.00
Contineum Therapeutics (CTNM) United States $0.356B 0.00
ACELYRIN, INC (SLRN) United States $0.355B 0.00
Design Therapeutics (DSGN) United States $0.348B 0.00
Sage Therapeutics (SAGE) United States $0.347B 0.00
Voyager Therapeutics (VYGR) United States $0.341B 8.80
Kamada (KMDA) Israel $0.333B 20.68
Neurogene (NGNE) United States $0.332B 0.00
XOMA Royalty (XOMA) United States $0.330B 0.00
Prima BioMed (IMMP) Australia $0.325B 0.00
Revance Therapeutics (RVNC) United States $0.324B 0.00
Foghorn Therapeutics (FHTX) United States $0.321B 0.00
Candel Therapeutics (CADL) United States $0.318B 0.00
Eton Pharmaceuticals (ETON) United States $0.314B 0.00
Jasper Therapeutics (JSPR) United States $0.307B 0.00
Tango Therapeutics (TNGX) United States $0.306B 0.00
C4 Therapeutics (CCCC) United States $0.305B 0.00
AC Immune (ACIU) Switzerland $0.296B 0.00
EnGene Holdings (ENGN) Canada $0.291B 0.00
ITeos Therapeutics (ITOS) United States $0.290B 0.00
Benitec Biopharma (BNTC) United States $0.287B 0.00
Mersana Therapeutics (MRSN) United States $0.284B 0.00
Lifecore Biomedical (LFCR) United States $0.279B 0.00
Trevi Therapeutics (TRVI) United States $0.277B 0.00
Renovaro (RENB) United States $0.273B 0.00
BioStem Technologies (BSEM) $0.270B 23.89
Vanda Pharmaceuticals (VNDA) United States $0.269B 0.00
Urogen Pharma (URGN) United States $0.269B 0.00
Rezolute (RZLT) United States $0.269B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.269B 0.00
Chimerix (CMRX) United States $0.264B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.263B 0.00
Artiva Biotherapeutics (ARTV) United States $0.259B 0.00
Abeona Therapeutics (ABEO) United States $0.257B 0.00
Nautilus Biotechnology (NAUT) United States $0.256B 0.00
Anika Therapeutics (ANIK) United States $0.254B 0.00
ATyr Pharma (ATYR) United States $0.254B 0.00
Atea Pharmaceuticals (AVIR) United States $0.249B 0.00
Ocugen (OCGN) United States $0.248B 0.00
DiaMedica Therapeutics (DMAC) United States $0.241B 0.00
TuHURA Biosciences (HURA) United States $0.227B 0.00
Molecular Partners AG (MOLN) Switzerland $0.224B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.223B 0.00
Fate Therapeutics (FATE) United States $0.219B 0.00
Tenaya Therapeutics (TNYA) United States $0.218B 0.00
Fulcrum Therapeutics (FULC) United States $0.217B 0.00
Inhibrx Biosciences (INBX) United States $0.214B 0.00
XBiotech (XBIT) United States $0.211B 0.00
Biomea Fusion (BMEA) United States $0.210B 0.00
Precigen (PGEN) United States $0.209B 0.00
Compass Therapeutics (CMPX) United States $0.208B 0.00
Gossamer Bio (GOSS) United States $0.206B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.203B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.202B 0.00
Verastem (VSTM) United States $0.200B 0.00
Alector (ALEC) United States $0.200B 0.00
Opthea (OPT) Australia $0.193B 0.00
Kyverna Therapeutics (KYTX) United States $0.193B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.191B 0.00
Inozyme Pharma (INZY) United States $0.191B 0.00
GENFIT S.A (GNFT) France $0.191B 0.00
Climb Bio (CLYM) United States $0.190B 0.00
Amarin (AMRN) Ireland $0.189B 0.00
Solid Biosciences (SLDB) United States $0.187B 0.00
Checkpoint Therapeutics (CKPT) United States $0.186B 0.00
Sutro Biopharma (STRO) United States $0.181B 0.00
CAMP4 Therapeutics (CAMP) United States $0.179B 0.00
Semper Paratus Acquisition (TVGN) United States $0.177B 0.00
Caribou Biosciences (CRBU) United States $0.176B 0.00
Bright Minds Biosciences (DRUG) United States $0.175B 0.00
Greenwich LifeSciences (GLSI) United States $0.174B 0.00
Coherus BioSciences (CHRS) United States $0.173B 0.00
Ventyx Biosciences (VTYX) United States $0.173B 0.00
2seventy Bio (TSVT) United States $0.172B 0.00
Repare Therapeutics (RPTX) Canada $0.169B 0.00
PepGen (PEPG) United States $0.168B 0.00
Adherex Technologies (FENC) United States $0.168B 0.00
Cardiff Oncology (CRDF) United States $0.167B 0.00
ScPharmaceuticals (SCPH) United States $0.166B 0.00
BioAge Labs (BIOA) United States $0.165B 0.00
Actuate Therapeutics (ACTU) United States $0.162B 0.00
Nkarta (NKTX) United States $0.162B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.162B 0.00
TScan Therapeutics (TCRX) United States $0.161B 0.00
Editas Medicine (EDIT) United States $0.156B 0.00
Cidara Therapeutics (CDTX) United States $0.152B 0.00
Seres Therapeutics (MCRB) United States $0.147B 0.00
Seer (SEER) United States $0.145B 0.00
Cabaletta Bio (CABA) United States $0.144B 0.00
Compugen (CGEN) Israel $0.144B 80.50
Zura Bio (ZURA) United States $0.144B 0.00
Puma Biotechnology (PBYI) United States $0.143B 6.08
Black Diamond Therapeutics (BDTX) United States $0.141B 0.00
Instil Bio (TIL) United States $0.140B 0.00
Sagimet Biosciences (SGMT) United States $0.139B 0.00
Elutia (ELUT) United States $0.137B 0.00
InflaRx (IFRX) Germany $0.136B 0.00
Applied Therapeutics (APLT) United States $0.133B 0.00
Inventiva S.A (IVA) France $0.130B 0.00
Monopar Therapeutics (MNPR) United States $0.128B 0.00
Innate Pharma S.A (IPHA) France $0.126B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.124B 0.00
Akoya Biosciences (AKYA) United States $0.120B 0.00
Leap Therapeutics (LPTX) United States $0.120B 0.00
Adverum Biotechnologies (ADVM) United States $0.119B 0.00
Aligos Therapeutics (ALGS) United States $0.119B 0.00
TELA Bio (TELA) United States $0.112B 0.00
INmune Bio (INMB) United States $0.108B 0.00
MediciNova (MNOV) United States $0.105B 0.00
Alto Neuroscience (ANRO) United States $0.103B 0.00
Cellectis S.A (CLLS) France $0.103B 0.00
X4 Pharmaceuticals (XFOR) United States $0.102B 0.00
Immunic (IMUX) United States $0.102B 0.00
Skye Bioscience (SKYE) United States $0.102B 0.00
BioHarvest Sciences (BHST) Canada $0.101B 0.00
Rani Therapeutics Holdings (RANI) United States $0.100B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.099B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.099B 0.00
Scilex Holding (SCLX) United States $0.099B 0.00
HilleVax (HLVX) United States $0.099B 0.00
Inovio Pharmaceuticals (INO) United States $0.098B 0.00
Invizyne Technologies (IZTC) United States $0.098B 0.00
Coya Therapeutics (COYA) United States $0.097B 0.00
Genenta Science S.p.A (GNTA) Italy $0.097B 0.00
Allakos (ALLK) United States $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.094B 0.00
Adagene (ADAG) China $0.093B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.092B 0.00
Quince Therapeutics (QNCX) United States $0.090B 0.00
Nuvectis Pharma (NVCT) United States $0.090B 0.00
CytomX Therapeutics (CTMX) United States $0.088B 6.59
Genelux (GNLX) United States $0.087B 0.00
23andMe Holding (ME) United States $0.087B 0.00
Abpro Holdings (ABP) United States $0.082B 0.00
Vigil Neuroscience (VIGL) United States $0.082B 0.00
I-Mab (IMAB) China $0.082B 0.00
Adlai Nortye (ANL) Cayman Islands $0.081B 0.00
Adicet Bio (ACET) United States $0.080B 0.00
Ikena Oncology (IKNA) United States $0.080B 0.00
Generation Bio (GBIO) United States $0.079B 0.00
DBV Technologies S.A (DBVT) France $0.079B 0.00
Entera Bio (ENTX) Israel $0.079B 0.00
FibroBiologics (FBLG) United States $0.079B 0.00
Annovis Bio (ANVS) United States $0.077B 0.00
Werewolf Therapeutics (HOWL) United States $0.076B 0.00
Clearside Biomedical (CLSD) United States $0.076B 0.00
Ovid Therapeutics (OVID) United States $0.075B 0.00
ALX Oncology Holdings (ALXO) United States $0.075B 0.00
Aerovate Therapeutics (AVTE) United States $0.074B 0.00
Bluebird Bio (BLUE) United States $0.074B 0.00
Agenus (AGEN) United States $0.072B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.071B 0.00
PDS Biotechnology (PDSB) United States $0.071B 0.00
ZIVO Bioscience (ZIVO) United States $0.070B 0.00
Invivyd (IVVD) United States $0.069B 0.00
BioAtla (BCAB) United States $0.069B 0.00
VistaGen Therapeutics (VTGN) United States $0.069B 0.00
Vor Biopharma (VOR) $0.067B 0.00
BeyondSpring (BYSI) United States $0.067B 0.00
Cue Biopharma (CUE) United States $0.066B 0.00
Boundless Bio (BOLD) United States $0.066B 0.00
Theratechnologies (THTX) Canada $0.065B 0.00
Oncolytics Biotech (ONCY) Canada $0.064B 0.00
Connect Biopharma Holdings (CNTB) United States $0.064B 0.00
Atara Biotherapeutics (ATRA) United States $0.063B 0.00
BGM Group (BGM) China $0.062B 0.00
Immuneering (IMRX) United States $0.061B 0.00
Galena Biopharma (SLS) United States $0.061B 0.00
Kronos Bio (KRON) United States $0.060B 0.00
Spero Therapeutics (SPRO) United States $0.060B 15.71
Aadi Bioscience (AADI) United States $0.059B 0.00
Immix Biopharma (IMMX) United States $0.059B 0.00
Shattuck Labs (STTK) United States $0.057B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.056B 0.00
Fortress Biotech (FBIO) United States $0.055B 0.00
Omega Therapeutics (OMGA) United States $0.054B 0.00
Elicio Therapeutics (ELTX) United States $0.054B 0.00
Enzo Biochem (ENZ) United States $0.054B 0.00
IO Biotech (IOBT) Denmark $0.052B 0.00
Q32 Bio (QTTB) United States $0.052B 0.00
Celularity (CELU) United States $0.051B 0.00
VTv Therapeutics (VTVT) United States $0.050B 0.00
Kezar Life Sciences (KZR) United States $0.049B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.049B 0.00
Passage Bio (PASG) United States $0.048B 0.00
Dyadic (DYAI) United States $0.048B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.047B 0.00
Precision BioSciences (DTIL) United States $0.047B 0.00
Rallybio (RLYB) United States $0.046B 0.00
Exicure (XCUR) United States $0.046B 0.00
Xilio Therapeutics (XLO) United States $0.045B 0.00
Estrella Immunopharma (ESLA) United States $0.045B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.045B 0.00
AN2 Therapeutics (ANTX) United States $0.044B 0.00
Aileron Therapeutics (ALRN) United States $0.044B 0.00
Clene (CLNN) United States $0.041B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.041B 0.00
Elevation Oncology (ELEV) United States $0.040B 0.00
Grace Therapeutics (GRCE) Canada $0.040B 0.00
Lexaria Bioscience (LEXX) Canada $0.039B 0.00
Lantern Pharma (LTRN) United States $0.039B 0.00
CalciMedica (CALC) United States $0.038B 0.00
Lumos Pharma (LUMO) United States $0.038B 0.00
Oncobiologics (OTLK) United States $0.036B 0.00
OnKure Therapeutics (OKUR) United States $0.036B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.036B 0.00
Rapt Therapeutics (RAPT) United States $0.036B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
SAB Biotherapeutics (SABS) United States $0.036B 0.00
Beyond Air (XAIR) United States $0.035B 0.00
Affimed (AFMD) Germany $0.035B 0.00
Opus Genetics (IRD) United States $0.035B 0.00
Alpha Cognition (ACOG) Canada $0.035B 0.00
Forte Biosciences (FBRX) United States $0.034B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.033B 0.00
RenovoRx (RNXT) United States $0.032B 0.00
Curis (CRIS) United States $0.032B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
NextCure (NXTC) United States $0.031B 0.00
Medicus Pharma (MDCX) Canada $0.030B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.030B 0.00
Gelteq (GELS) Australia $0.029B 0.00
Intensity Therapeutics (INTS) United States $0.029B 0.00
KALA BIO (KALA) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Longeveron (LGVN) United States $0.028B 0.00
Femasys (FEMY) United States $0.027B 0.00
Pluri (PLUR) Israel $0.027B 0.00
HOOKIPA Pharma (HOOK) United States $0.026B 0.00
Senti Biosciences (SNTI) United States $0.026B 0.00
MiNK Therapeutics (INKT) United States $0.025B 0.00
Equillium (EQ) United States $0.025B 0.00
Chemomab Therapeutics (CMMB) Israel $0.024B 0.00
Bionano Genomics (BNGO) United States $0.024B 0.00
BRIACELL THERAP (BCTX) Canada $0.024B 0.00
LakeShore Biopharma (LSB) China $0.024B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
GeoVax Labs (GOVX) United States $0.023B 0.00
Ocean Biomedical (OCEA) United States $0.023B 0.00
Athira Pharma (ATHA) United States $0.023B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.021B 0.00
Pulmatrix (PULM) United States $0.021B 0.00
Cognition Therapeutics (CGTX) United States $0.021B 0.00
IN8bio (INAB) United States $0.021B 0.00
Bolt Biotherapeutics (BOLT) United States $0.020B 0.00
Tenax Therapeutics (TENX) United States $0.020B 0.00
MetaVia (MTVA) United States $0.020B 0.00
Cadrenal Therapeutics (CVKD) United States $0.019B 0.00
Aprea Therapeutics (APRE) United States $0.019B 0.00
Cocrystal Pharma (COCP) United States $0.019B 0.00
UNITY Biotechnology (UBX) United States $0.019B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.019B 0.00
Synlogic (SYBX) United States $0.018B 0.00
BioXcel Therapeutics (BTAI) United States $0.018B 0.00
NKGen Biotech (NKGN) United States $0.018B 0.00
Cyclo Therapeutics (CYTH) United States $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
Spruce Biosciences (SPRB) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
BioAffinity Technologies (BIAF) United States $0.015B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.015B 0.00
HCW Biologics (HCWB) United States $0.015B 0.00
Cara Therapeutics (CARA) United States $0.014B 0.00
Cingulate (CING) United States $0.014B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Imunon (IMNN) United States $0.012B 0.00
CervoMed (CRVO) United States $0.012B 0.00
Aptose Biosciences (APTO) Canada $0.012B 0.00
Mainz Biomed (MYNZ) Germany $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
Apollomics (APLM) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Quantum Biopharma (QNTM) Canada $0.008B 0.00
Ensysce Biosciences (ENSC) United States $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Eyenovia (EYEN) United States $0.008B 0.00
GRI Bio (GRI) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Evaxion Biotech (EVAX) Denmark $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Syros Pharmaceuticals (SYRS) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Vincerx Pharma (VINC) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Elevai Labs (ELAB) United States $0.006B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Carmell (CTCX) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
NAYA Biosciences (NAYA) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00